Vice President & Global Program Head

VP, Head of Content Lab

Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU)

Novartis' skin disease drug gets US approval

Swiss stocks - Factors to watch on October 1

Novartis' Immunology Portfolio Bolstered as US FDA Approves Chronic Spontaneous Urticaria Drug

Cell Processing Specialist I

Novartis is a leading manufacturer of Cell & Gene therapies located in Morris Plains, NJ. The Cell Processing Specialist I is responsible for cell washing operations and verifying cell processing for patient-derived clinical and commercial cellular immunotherapy products, ensuring high proficiency and ownership of the process.

Cell Processing Specialist I, (Sun-Thurs, PM)

Head of US Benefits

Talent Acquisition

Senior Principal Scientist | Lab Head – Neurodegeneration & Lipid Biology

Cell Processing Specialist

Sr. Cell Processing Specialist

Sign up with Google

Sign in with Google